Neovascularization, Pathologic clinical trials

The registry lists 81 studies for Neovascularization, Pathologic across more than 10 countries. 7 are recruiting or about to start. 17 of them are mainly about Neovascularization, Pathologic (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-12. Counting its 4 narrower conditions too, such as Choroidal Neovascularization: 386 studies, 31 open.

Get an email when these change. Save the Neovascularization, Pathologic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 45
Status unknown: 19
Terminated: 5
Recruiting: 4
Active, not recruiting: 3
Not yet recruiting: 2

Phase

Phase 2: 16
Phase 1: 14
Phase 4: 6
Phase 3: 5
Early Phase 1: 2

Where

United States: 27
France: 7
Brazil: 4
Italy: 3
Canada: 3
Germany: 3

Who runs them

Instituto de Olhos de Goiania (4) · National Eye Institute (NEI) (3) · Maastricht University Medical Center (2) · Rafic Hariri University Hospital (2) · Sun Yat-sen University (2) · Children's Hospital Medical Center, Cincinnati (2) · Shionogi (2) · University Hospital, Tours (2)

What is being tested here

Drugs under test in Neovascularization, Pathologic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Rubidium-82	1	0	1
Aflibercept	0	0	7
Ranibizumab	0	1	7
Bevacizumab	0	1	4
S 3304	0	0	2
Glucose	0	1	2
RBM-007	0	0	1
Zoledronic Acid	0	0	1
Doxycycline	0	0	1
Sozinibercept	0	0	1

Drug classes tested here Angiogenesis inhibitors 18

Coming up

0phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Nov 2026Enhanced External Counterpulsation for Patients With Ventilation Disorders · I.M. Sechenov First Moscow State Medical University
Jan 2027Study of Pregnancy Pathologies Associated With Placental Abnormalities · University Hospital, Grenoble
Jul 2027Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery · Universidad Complutense de Madrid

Who these studies take

Of the 4 Neovascularization, Pathologic studies recruiting now, 2 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 1 (25%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	0 (0%)	0 (0%)
18	3 (75%)	2 (50%)
30	4 (100%)	3 (75%)
40	4 (100%)	3 (75%)
50	4 (100%)	3 (75%)
65	4 (100%)	3 (75%)
75	4 (100%)	3 (75%)
85	2 (50%)	1 (25%)

Across all 81 studies, recruiting or not: 32% stop at 75 or younger and 21% at 65; 10% take children; 12% are for women only and 2% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 → or search them.